SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-584714
Filing Date
2016-05-10
Accepted
2016-05-10 07:31:59
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d133483d10q.htm 10-Q 651035
2 EX-31.1 d133483dex311.htm EX-31.1 6781
3 EX-31.2 d133483dex312.htm EX-31.2 6755
4 EX-32.1 d133483dex321.htm EX-32.1 3521
5 EX-32.2 d133483dex322.htm EX-32.2 3478
  Complete submission text file 0001193125-16-584714.txt   2720199

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ocul-20160331.xml EX-101.INS 390161
7 XBRL TAXONOMY EXTENSION SCHEMA ocul-20160331.xsd EX-101.SCH 33851
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocul-20160331_cal.xml EX-101.CAL 52789
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocul-20160331_def.xml EX-101.DEF 95155
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20160331_lab.xml EX-101.LAB 276392
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20160331_pre.xml EX-101.PRE 180321
Mailing Address 34 CROSBY DRIVE SUITE 105 BEDFORD MA 01730
Business Address 34 CROSBY DRIVE SUITE 105 BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 161633701
SIC: 2834 Pharmaceutical Preparations